Clinical Trial: A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755410) titled 'A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)' on Aug. 05.

Brief Summary: The purpose of this study is to measure safety and the improvement in symptoms in subjects with ADHD when taking ALKS 7290 tablets compared with placebo tablets.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Attention Deficit Disorder With Hyperactivity (ADHD)

Intervention: DRUG: ALKS 7290

ALKS 7290 tablets taken daily, orally, for 4 weeks

DRUG: Placebo

Placebo capsule taken daily

Recruitment Status: RECRUITING

Sponso...